Bionano Genomics Inc
NASDAQ:BNGO 4:00:00 PM EDT
| Market Cap (Intraday) | 48.20M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.92 |
| 50-Day MA | $1.10 |
| 200-Day MA | $2.34 |
Bionano Genomics Inc Stock, NASDAQ:BNGO
9540 Towne Centre Drive, Suite 100, San Diego, California 92121
United States of America
Phone: +1.858.888.7600
Number of Employees: 344
Description
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.